ALLMedicine™ Heart Failure Center

Mar 5th, 2021 - Rationale: The compensatory activation of the renin-angiotensin system (RAS) after myocardial infarction (MI) plays a crucial role in the pathogenesis of heart failure. Most existing studies on this subject focus on mono- or dual-therapy of blocki...

Mar 5th, 2021 - Cardiac resynchronization therapy (CRT) is a well-established treatment for patients with drug refractory heart failure OBJECTIVES: This study sought to compare the longest RVsense to LVsense activation time (sLAT) versus the longest RVpace to LVs...

Mar 5th, 2021 - Cardiac glycosides (CGs) inhibit the Na+ ,K+ -ATPase and are widely prescribed medicines for chronic heart failure and cardiac arrhythmias. Recently, CGs have been described to induce inflammasome activation and pyroptosis in human macrophages, su...

Mar 5th, 2021 - Left ventricular assist device (LVAD) support is associated with peripheral vascular abnormalities beyond those associated with heart failure (HF). These abnormalities are associated with persistent functional impairments that adversely impact qua...

Mar 5th, 2021 - Background Previous studies have suggested that sleep timing is associated with cardiovascular risk factors. However, there is no evidence on the relationship between sleep timing and congestive heart failure (CHF). We aimed to examine this relati...

Feb 8th, 2021 - DALLAS, Feb. 9, 2021 — Dietary information from three large, well-known heart disease studies suggests drinking one or more cups of caffeinated coffee may reduce heart failure risk, according to research published today in Circulation: Heart Failu...

Jan 15th, 2021 - 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set...

Nov 6th, 2020 - 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.|2020|Heidenreich PA,Fonarow GC,Breathett K,Jurgens ...

Oct 16th, 2020 - Integrated electrophysiology care for patients with heart failure: An envisioned future.|2020|Mason PK,Desai A,Ajijola OA,Amin AK,Barbhaiya C,|

Aug 25th, 2020 - Patients with heart failure (HF) are more at risk of developing cancer than the general population.

Mar 5th, 2021 - Rationale: The compensatory activation of the renin-angiotensin system (RAS) after myocardial infarction (MI) plays a crucial role in the pathogenesis of heart failure. Most existing studies on this subject focus on mono- or dual-therapy of blocki...

Mar 5th, 2021 - Cardiac resynchronization therapy (CRT) is a well-established treatment for patients with drug refractory heart failure OBJECTIVES: This study sought to compare the longest RVsense to LVsense activation time (sLAT) versus the longest RVpace to LVs...

Mar 5th, 2021 - Cardiac glycosides (CGs) inhibit the Na+ ,K+ -ATPase and are widely prescribed medicines for chronic heart failure and cardiac arrhythmias. Recently, CGs have been described to induce inflammasome activation and pyroptosis in human macrophages, su...

Mar 5th, 2021 - Left ventricular assist device (LVAD) support is associated with peripheral vascular abnormalities beyond those associated with heart failure (HF). These abnormalities are associated with persistent functional impairments that adversely impact qua...

Mar 5th, 2021 - Background Previous studies have suggested that sleep timing is associated with cardiovascular risk factors. However, there is no evidence on the relationship between sleep timing and congestive heart failure (CHF). We aimed to examine this relati...

Feb 24th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The majority of COVID-19 hospitalizations in the United States are attributable to four preexisting cardiometabolic conditions, a new study sugges...

Feb 22nd, 2021 - Dapagliflozin's benefits in patients with heart failure with reduced ejection fraction appeared quickly after treatment began, and patients who had been hospitalized for heart failure within the prior year got the biggest boost from the drug, acco...

Feb 21st, 2021 - One of the ways to diagnose high blood pressure is with a 24-hour blood pressure monitor. In healthy people, nocturnal blood pressure dips by about 15% compared with daytime values. Patients who don't have this blood pressure drop at night, often ...

Feb 16th, 2021 - Dr Bernard Lown walks on the bridge renamed in his honor in Lewiston, Maine. BOSTON (AP) — Dr. Bernard Lown, a Massachusetts cardiologist who invented the first reliable heart defibrillator and later co-founded an anti-nuclear war group that was a...

Feb 16th, 2021 - The US Food and Drug Administration (FDA) has approved a groundbreaking expanded indication for sacubitril/valsartan (Entresto), making it the first drug in the United States indicated for chronic heart failure (HF) not specifically characterized ...